𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NF-κB suppresses ROS levels in BCR–ABL+ cells to prevent activation of JNK and cell death

✍ Scribed by Stein, S J; Baldwin, A S


Book ID
109972836
Publisher
Nature Publishing Group
Year
2011
Tongue
English
Weight
759 KB
Volume
30
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


NF-κB inhibition triggers death of imati
✍ Nadia Lounnas; Catherine Frelin; Nadège Gonthier; Pascal Colosetti; Anne Sirvent 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 521 KB

## Abstract The Bcr‐Abl inhibitor imatinib is the current first‐line therapy for all newly diagnosed chronic myeloid leukemia (CML). Nevertheless, resistance to imatinib emerges as CML progresses to an acute deadly phase implying that physiopathologically relevant cellular targets should be validat